 Johannes von Alvensleben
Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Dysfunction, Left | 7 | 2022 | 361 | 2.100 |
Why?
| | Electrocardiography | 8 | 2023 | 562 | 2.030 |
Why?
| | Heart Defects, Congenital | 8 | 2023 | 665 | 1.760 |
Why?
| | Arrhythmias, Cardiac | 5 | 2023 | 278 | 1.560 |
Why?
| | Catheter Ablation | 6 | 2023 | 291 | 1.530 |
Why?
| | Tachycardia, Supraventricular | 3 | 2022 | 42 | 1.530 |
Why?
| | Tachycardia, Ventricular | 6 | 2023 | 153 | 1.430 |
Why?
| | Defibrillators, Implantable | 4 | 2023 | 286 | 1.000 |
Why?
| | Heart Conduction System | 2 | 2020 | 82 | 0.830 |
Why?
| | Ventricular Premature Complexes | 1 | 2022 | 26 | 0.820 |
Why?
| | Syncope | 2 | 2023 | 37 | 0.760 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.680 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2019 | 218 | 0.670 |
Why?
| | Diagnostic Imaging | 1 | 2021 | 290 | 0.630 |
Why?
| | Tetralogy of Fallot | 4 | 2023 | 84 | 0.630 |
Why?
| | Heart Atria | 2 | 2023 | 111 | 0.600 |
Why?
| | Anti-Arrhythmia Agents | 2 | 2021 | 106 | 0.580 |
Why?
| | Nadolol | 1 | 2016 | 5 | 0.570 |
Why?
| | Flecainide | 1 | 2016 | 7 | 0.560 |
Why?
| | Heart Rate | 1 | 2020 | 705 | 0.560 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 135 | 0.550 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2017 | 79 | 0.550 |
Why?
| | Fontan Procedure | 3 | 2023 | 157 | 0.540 |
Why?
| | Pacemaker, Artificial | 1 | 2017 | 107 | 0.530 |
Why?
| | Child | 23 | 2023 | 18407 | 0.510 |
Why?
| | Cardiac Surgical Procedures | 2 | 2022 | 413 | 0.500 |
Why?
| | Pediatrics | 2 | 2020 | 981 | 0.500 |
Why?
| | Pulmonary Valve | 4 | 2023 | 88 | 0.500 |
Why?
| | Retrospective Studies | 18 | 2023 | 12547 | 0.500 |
Why?
| | Ventricular Function, Left | 4 | 2023 | 469 | 0.490 |
Why?
| | Heart Septum | 1 | 2014 | 26 | 0.490 |
Why?
| | Punctures | 1 | 2014 | 36 | 0.480 |
Why?
| | Death, Sudden, Cardiac | 5 | 2023 | 160 | 0.420 |
Why?
| | Adolescent | 18 | 2023 | 17864 | 0.390 |
Why?
| | Treatment Outcome | 10 | 2023 | 9122 | 0.380 |
Why?
| | Cardiac Catheterization | 1 | 2014 | 535 | 0.370 |
Why?
| | Atrioventricular Block | 2 | 2022 | 37 | 0.340 |
Why?
| | Postoperative Complications | 3 | 2020 | 2150 | 0.330 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2023 | 174 | 0.330 |
Why?
| | Long QT Syndrome | 3 | 2019 | 59 | 0.330 |
Why?
| | Cardiomyopathy, Hypertrophic | 3 | 2019 | 122 | 0.320 |
Why?
| | Humans | 32 | 2023 | 115042 | 0.310 |
Why?
| | Myocardial Contraction | 2 | 2020 | 313 | 0.310 |
Why?
| | Hemodynamics | 3 | 2021 | 1017 | 0.290 |
Why?
| | Aortic Valve Stenosis | 2 | 2022 | 272 | 0.290 |
Why?
| | Michigan | 3 | 2016 | 96 | 0.280 |
Why?
| | Heart Transplantation | 2 | 2023 | 669 | 0.280 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 1736 | 0.280 |
Why?
| | Female | 20 | 2022 | 59613 | 0.250 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2023 | 42 | 0.250 |
Why?
| | Diastole | 2 | 2022 | 131 | 0.240 |
Why?
| | Principal Component Analysis | 1 | 2023 | 176 | 0.210 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2023 | 137 | 0.210 |
Why?
| | Male | 17 | 2021 | 55731 | 0.200 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 38 | 0.200 |
Why?
| | Catheters | 1 | 2022 | 65 | 0.200 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 1812 | 0.200 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 4 | 0.190 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2021 | 11 | 0.190 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 190 | 0.190 |
Why?
| | Bundle of His | 1 | 2021 | 16 | 0.190 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 22 | 0.190 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 6 | 0.190 |
Why?
| | Cardiac Electrophysiology | 1 | 2020 | 12 | 0.180 |
Why?
| | Fetal Heart | 1 | 2021 | 37 | 0.180 |
Why?
| | Electrophysiologic Techniques, Cardiac | 2 | 2018 | 70 | 0.180 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2021 | 59 | 0.180 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 110 | 0.180 |
Why?
| | Dextrocardia | 1 | 2019 | 3 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.170 |
Why?
| | Transposition of Great Vessels | 1 | 2019 | 29 | 0.170 |
Why?
| | Aortic Diseases | 1 | 2020 | 108 | 0.170 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2019 | 39 | 0.160 |
Why?
| | Software | 1 | 2023 | 537 | 0.160 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 364 | 0.160 |
Why?
| | Young Adult | 10 | 2021 | 10498 | 0.160 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.160 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2019 | 51 | 0.160 |
Why?
| | Atrial Fibrillation | 1 | 2023 | 325 | 0.160 |
Why?
| | Ebstein Anomaly | 1 | 2018 | 6 | 0.160 |
Why?
| | Infant, Newborn | 2 | 2021 | 5040 | 0.160 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 138 | 0.150 |
Why?
| | Heart Ventricles | 2 | 2023 | 714 | 0.150 |
Why?
| | Tachycardia, Reciprocating | 1 | 2017 | 6 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 4 | 2023 | 3118 | 0.140 |
Why?
| | Atrial Flutter | 1 | 2017 | 25 | 0.140 |
Why?
| | Bradycardia | 1 | 2017 | 48 | 0.140 |
Why?
| | Genetic Testing | 1 | 2019 | 380 | 0.140 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 175 | 0.140 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1355 | 0.130 |
Why?
| | Incidence | 3 | 2021 | 2318 | 0.130 |
Why?
| | Vascular Stiffness | 1 | 2020 | 408 | 0.130 |
Why?
| | Fetal Diseases | 1 | 2017 | 148 | 0.130 |
Why?
| | Age of Onset | 1 | 2016 | 449 | 0.120 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1539 | 0.110 |
Why?
| | Registries | 1 | 2021 | 1763 | 0.110 |
Why?
| | Heart Arrest | 1 | 2016 | 289 | 0.100 |
Why?
| | Mass Screening | 1 | 2019 | 1012 | 0.100 |
Why?
| | Databases, Factual | 1 | 2016 | 1132 | 0.100 |
Why?
| | Heart Diseases | 1 | 2014 | 330 | 0.090 |
Why?
| | Risk Factors | 4 | 2018 | 8642 | 0.090 |
Why?
| | Adult | 8 | 2021 | 30656 | 0.090 |
Why?
| | Electrocardiography, Ambulatory | 2 | 2021 | 54 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2021 | 3015 | 0.080 |
Why?
| | Infant | 2 | 2022 | 7946 | 0.080 |
Why?
| | Colorado | 1 | 2017 | 4089 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4420 | 0.070 |
Why?
| | Time Factors | 3 | 2021 | 6141 | 0.060 |
Why?
| | Child, Preschool | 4 | 2021 | 9093 | 0.060 |
Why?
| | Cohort Studies | 1 | 2014 | 4904 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3245 | 0.060 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 26 | 0.050 |
Why?
| | Fetal Monitoring | 1 | 2021 | 16 | 0.050 |
Why?
| | Esophagus | 1 | 2023 | 226 | 0.050 |
Why?
| | Mutation | 2 | 2021 | 3350 | 0.040 |
Why?
| | Swine | 1 | 2023 | 704 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 1962 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 578 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 372 | 0.040 |
Why?
| | Systole | 1 | 2020 | 171 | 0.040 |
Why?
| | Subcutaneous Tissue | 1 | 2019 | 17 | 0.040 |
Why?
| | Heart | 1 | 2023 | 610 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2799 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 40 | 0.040 |
Why?
| | Aortic Valve | 1 | 2022 | 399 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 922 | 0.040 |
Why?
| | British Columbia | 1 | 2018 | 10 | 0.040 |
Why?
| | Secondary Prevention | 1 | 2019 | 222 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 467 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 758 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 675 | 0.040 |
Why?
| | Primary Prevention | 1 | 2019 | 171 | 0.040 |
Why?
| | Germany | 1 | 2018 | 85 | 0.040 |
Why?
| | Pregnancy | 2 | 2021 | 5520 | 0.040 |
Why?
| | Perioperative Period | 1 | 2017 | 49 | 0.040 |
Why?
| | Coronary Vessel Anomalies | 1 | 2016 | 30 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2016 | 261 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 447 | 0.030 |
Why?
| | Calcium | 1 | 2021 | 1104 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2255 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 236 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 545 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 957 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1352 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 646 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1646 | 0.030 |
Why?
| | United States | 2 | 2021 | 12226 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1435 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 26827 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2359 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1839 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2815 | 0.020 |
Why?
| | Animals | 2 | 2023 | 31867 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 2894 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1715 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 2976 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6232 | 0.020 |
Why?
| | Mice | 1 | 2021 | 14927 | 0.020 |
Why?
|
|
von Alvensleben's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|